Assessment of Qatar community pharmacists’ competence and practices related to renal and gastrointestinal adverse effects of nonprescription NSAIDs

Bener, 2013, An epidemiologic analysis of low back pain in primary care: a hot humid country and global comparison, J. Prim Care Commun. Health, 4, 220, 10.1177/2150131913479385 Grimmer, 2002, Non-steroidal anti-inflammatory drugs (NSAIDs): physiotherapists' use, knowledge and attitudes, Aust. J. Physiother., 48, 82, 10.1016/S0004-9514(14)60202-6 Halila, 2015, Pharm. Pract. (Granada)., 13, 597, 10.18549/PharmPract.2015.04.597 Harirforoosh, 2013, Adverse effects of nonsteroidal antiinflammatory drugs: An update of gastrointestinal, cardiovascular and renal complications, J. Pharm. Pharm. Sci., 16, 821, 10.18433/J3VW2F Ibanez-Cuevas, 2008, Pharmacist intervention reduces gastropathy risk in patients using NSAIDs, Pharm. World Sci., 30, 947, 10.1007/s11096-008-9258-8 Institute for Safe Medication Practices, 2007. Protecting U.S. Citizens from Inappropriate Medication Use. A White Paper on Medication Safety in the U.S. and the Role of Community Pharmacists. https://communitypharmacyfoundation.org/docs/CPF_Doc_312222.pdf. Ipingbemi, 2016, Assessment of pharmacist's knowledge on use of non-steroidal anti-inflammatory drugs in hypertensive patients with co-morbid arthritis and pharmaceutical services rendered in Ibadan, Nigeria, West Afr. J. Pharm., 27, 16 Jang, 2014, NSAID-avoidance education in community pharmacies for patients at high risk for acute kidney injury, Upstate New York, 2011, Prev. Chronic Dis., 11, E220 Kaufman, 2018, Exceeding the daily dosing limit of nonsteroidal anti-inflammatory drugs among ibuprofen users, Pharmacoepidemiol. Drug Saf., 27, 322, 10.1002/pds.4391 Malebari, 2020, Evaluation of the community pharmacists’ performance in the screening of non-steroidal anti-inflammatory drugs risks in Saudi Arabia, Saudi Med. J., 41, 849, 10.15537/smj.2020.8.25221 Nielsen National Household Panel, Period of 52 weeks ending January 2018. https://www.nielsen.com/wp-content/uploads/sites/3/2019/04/december-2018-total-consumer-report.pdf. Oliviu, V., 2017. Adverse effects and drug interactions of the non‐steroidal anti‐inflammatory drugs, Nonsteroidal Anti-Inflammatory Drugs, Ali Gamal Ahmed Al-kaf, IntechOpen, DOI: 10.5772/intechopen.68198. Available from: https://www.intechopen.com/books/nonsteroidal-anti-inflammatory-drugs/adverse-effects-and-drug-interactions-of-the-non-steroidal-anti-inflammatory-drugs. Pai, 2015, Keeping kidneys safe: The pharmacist's role in NSAID avoidance in high-risk patients, J. Am. Pharm. Assoc., 55, e15, 10.1331/JAPhA.2015.15506 Phueanpinit, 2017, Physicians' communication of risks from non-steroidal anti-inflammatory drugs and attitude towards providing adverse drug reaction information to patients, J Eval Clin Pract., 23, 1387, 10.1111/jep.12806 Phueanpinit, 2018, Primary Health Care Res. Develop., 19, 598, 10.1017/S1463423618000142 Raosoft® Sample Size Calculator. Available online at http://www.raosoft.com/samplesize.html (accessed September 30, 2016). Silcock, 2007, Do community pharmacists have the attitudes and knowledge to support evidence based self-management of low back pain?, BMC Musculoskeletal Disorders, 8, 10, 10.1186/1471-2474-8-10 Teichert, 2014, Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users, Pharmacoepidemiol. Drug Saf., 23, 382, 10.1002/pds.3587 Vonkeman, 2010, Nonsteroidal anti-inflammatory drugs: Adverse effects and their prevention, Semin. Arthritis Rheum., 39, 294, 10.1016/j.semarthrit.2008.08.001 Wilcox, 2005, Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs, J. Rheumatol., 32, 2218